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1 Revisiting the equity debate in COVID-19: ICU is no panacea 
2
3 Abstract 
4 Throughout March and April 2020, debate raged about how best to allocate limited intensive 
5 care unit resources in the face of a growing COVID-19 pandemic. The debate was 
6 dominated by utility-based arguments for saving the most lives or life-years. These 
7 arguments were tempered by equity-based concerns that triage based solely on prognosis 
8 would exacerbate existing health inequities, leaving disadvantaged patients worse off. 
9 Central to this debate was the assumption that ICU admission is a valuable but scarce 
10 resource in the pandemic context. 
11 In this paper, we argue that the concern about achieving equity in ICU triage is problematic 
12 for two reasons. First, ICU can be futile and prolong or exacerbate suffering rather than 
13 ameliorate it. This may be especially true in COVID-19 patients with emerging data showing 
14 that most who receive access to a ventilator will still die. There is no value in admitting 
15 patients with poor prognostic indicators to ICU to meet an equity target when intensive 
16 critical care is contrary to their best interests.  Second, the focus on ICU admission shifts 
17 focus away from important aspects of COVID-19 care where there is greater opportunity for 
18 mitigating suffering and enhancing equitable care.
19 We propose that the focus on equity concerns during the pandemic should broaden to 
20 include providing all people who need it with access to the highest possible standard of end 
21 of life care. This requires attention to culturally safe care in the following interlinked areas: 
22 palliative care, communication and decision support and advanced care planning. 
23
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25 Introduction
26 As COVID-19 spread internationally, healthcare services in many countries became 
27 overwhelmed. One of the main manifestations of this was a shortage of intensive care beds, 
28 leading to urgent discussion about how to allocate these fairly. In the initial debates about 
29 allocation of scarce ICU beds, there was optimism about the ‘good’ of intensive care unit 
30 (ICU) access. However, rather than being a life-saving intervention, data began to emerge in 
31 mid-April showing that most critical COVID-19 patients who receive access to a ventilator do 
32 not survive to discharge. The minority who survive leave the ICU with significant morbidity 
33 and a long and uncertain road to recovery.  This reality remains under-recognised in the 
34 bioethics literature on ICU triage. Throughout March and April 2020, debate raged about 
35 how best to allocate limited intensive care unit resources in the face of the growing COVID-
36 19 pandemic. Central to this debate were two assumptions: first, that ICU admission was a 
37 valuable but scarce resource in the pandemic context; and second, that both equity and 
38 utility considerations were important in determining which patients should have access to 
39 ICU. In this paper we explain how scarcity and value were conflated in the early ICU COVID 
40 triage literature, leading to undue optimism about the ‘good’ of ICU access, which in turned 
41 fuelled equity-based arguments for ICU access. In the process, ethical issues arising 
42 regarding equitable access to end of life care more broadly were neglected.
43
44 Equity requires the prevention of avoidable or remediable differences among social, 
45 economic, demographic, or geographic groups.(1)  How best to apply an equity lens to 
46 questions of distribution will depend on the nature of the resource in question. Equitable 
47 distribution of ICU beds is significantly more complex than equitable distribution of other 
48 goods that might be scarce in a pandemic, such as masks or vaccines if available.  ICU 
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49 (especially that which involves intubation and ventilation i.e. mechanical ventilation) is a 
50 burdensome treatment option that can lead to significant suffering – both short and long 
51 term. The degree to which these burdens are justified depends on the probability of benefit, 
52 and this depends on the clinical status of the patient. People are rightly concerned about the 
53 equity implications of excluding patients from ICU on the grounds of pre-existing co-
54 morbidities that directly affect prognosis, especially when these align with and reflect social 
55 disadvantage. But this does not mean that aged, frail or comorbid patients should be 





61 ICU triage debate 
62 The COVID-19 pandemic has generated extraordinary demand for critical care and required 
63 hard choices about who will receive presumed life-saving interventions such as ICU 
64 admission. The debate has focused on whether or not a utilitarian approach aimed at 
65 maximizing the number of lives (or life years) saved should be supplemented by equity 
66 considerations that attempt to protect the rights and interests of members of marginalized 
67 groups. The utilitarian approach uses criteria for access to ICU that focus on capacity to 
68 benefit, understood as survival.(2) Supplementary equity considerations have been invoked 
69 to relax the criteria in order to give a more diverse group of people a chance of entering 
70 ICU.(3,4) 
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71 Equity-based critiques are grounded in the concern that a utilitarian approach aimed at 
72 maximizing the number (or length) of lives saved may well exacerbate inequity in survival 
73 rates between groups. This potential for discrimination is heightened if triage tools use age 
74 as a proxy for capacity to benefit or are heavily reliant on QALYs (which will deprioritize 
75 people with disabilities).(5,6)  Even if these pitfalls are avoided, policies based on 
76 maximizing lives saved entrench existing heath inequalities because those most likely to 
77 benefit from treatment will be people of privilege who come into the pandemic with better 
78 health status than less advantaged people. Those from lower socioeconomic groups, and/or 
79 some ethnic minorities have high rates of underlying comorbidities, some of which are 
80 prognostically relevant in COVID-19 infection. Public health ethics requires that we 
81 acknowledge how apparently neutral triage tools reflect and reinforce these disparities, 
82 especially where the impact can be lethal.(7)
83 But the utility versus equity debate is more complex than it first appears.  Both the utility and 
84 equity approach to ICU triage start from the assumption that ICU is a valuable good – the 
85 dispute is about how best to allocate it. Casting ICU admission as a scarce good subject to 
86 rationing has the (presumably unintended) effect of making access to critical care look highly 
87 appealing, triggering cognitive biases. Psychologists and marketers know that scarcity 
88 sells.(8) People value a commodity more when it is difficult or impossible to obtain.(9) When 
89 there is competition for scarce resources, people focus less on whether they really need or 
90 want the resource. The priority becomes securing access to the resource. 
91
92 Clinicians are not immune to scarcity-related cognitive bias. Clinicians treating COVID-19 
93 patients are working under conditions of significant information overload but without the high 
94 quality clinical research (generated from large data sets and rigorous methodology) usually 
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95 available for decision-making. The combination of overwhelming numbers of patients, high 
96 acuity and uncertainty regarding best practice is highly anxiety provoking.  In this context it is 
97 unsurprising that, at least in the early stages of the pandemic, they may not have the 
98 psychological bandwidth to challenge assumptions about the benefits of ICU admission for 
99 patients with severe disease.  Zagury-Orly and Schwartzstein have recently argued that the 
100 health sector must accept that doctors’ reasoning and decision-making are susceptible to 
101 human anxieties and in the “…effort to “do good” for our patients, we may fall prey to 
102 cognitive biases and therapeutic errors”.(10)  
103
104 We suggest the global publicity and panic regarding ICU triage distorted assessments of 
105 best interests and decision-making about admittance to ICU and slanted ethical debate.  
106 This has the potential to compromise important decisions with regard to patient care in 
107 COVIDD-19 patients 
108
109
110 The emerging reality of ICU 
111 In general, the majority of patients who are ventilated for COVID-19 in ICU will die.  Although 
112 comparing data from different health systems is challenging due to variation in admission 
113 criteria for ICU, clear trends are emerging with regard to those critically unwell and requiring 
114 mechanical ventilation. Emerging data show case fatality rates (CFRs) of 50% - 88% for 
115 ventilated COVID-19 patients.  In China(11) and Italy about half of those with COVID-19 who 
116 receive ventilator support have not survived.(12) In one small study in Wuhan the ICU 
117 mortality rate among those who received invasive mechanical ventilation was 86% 
118 (19/22).(13) Interestingly, the rate among those who received less intensive non-invasive 
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119 ventilation (NIV) 1  was still 79% (23/29).(13) Analysis of 5,700 patients in the New York City 
120 area showed that the mortality for those receiving mechanical ventilation was 88%.(14) In 
121 the UK, only 20% of those who have received mechanical ventilation in the UK have been 
122 discharged alive.(15) Hence, the very real possibility of medical futility with regard to 
123 ventilation in COVID-19 needs to be considered.
124 It is also important to consider the complications and side effects that occur in an ICU 
125 context.  These patients are vulnerable to hospital acquired infections such as ventilator 
126 associated pneumonias (VAP) with high mortality rates in their own right (16), neuropathies, 
127 myopathies (17) and skin damage.  Significant long term morbidity (physical, mental and 
128 emotional challenges) can also be experienced by people who survive prolonged ventilation 
129 in ICU.(18,19) Under normal (non-emergency) circumstances, many patients experience 
130 significant muscle atrophy and deconditioning, sleep disorders, severe fatigue (20), PTSD 
131 (21), cognitive deficits (22), depression, anxiety, difficulty with daily activities and loss of 
132 employment (23). Although it is too soon to have data on the long term outcomes of ICU 
133 survivors in the specific context of COVID-19, the UK the Chartered Society of 
134 Physiotherapy predicts a “tsunami of rehabilitation needs” as COVID patients begin to be 
135 discharged.(24)  The indirect effects of carer-burden should also not be underestimated as 
136 research shows that caring for patients who have survived critical illness results in high 
137 levels of depressive symptoms for the majority of caregivers.(25)
138 The emerging mortality data for COVID-19 patients admitted to ICU – in conjunction with 
139 what is already know about the morbidity of ICU survivors – has significant implications for 
140 the utility-equity debates about allocating the scarce resource of ICU beds. First, they 
1 NIV does not require a general anaesthetic and intubation.  Patients receive airway pressure support and 
oxygen but they remain conscious.
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141 undermine the utility argument as there seems to be little evidence that ICU admission leads 
142 to better outcomes for patients, especially when the long term morbidity of extended ICU 
143 admission is included in the balance of burdens and benefits. For some patients, perhaps 
144 many, the burdens of ICU will not outweigh the limited potential benefits. Second, the poor 
145 survival rates challenge the equity-based claim for preferential access to treatment for 
146 members of disadvantaged groups. In particular, admitting frailer or comorbid patients to ICU 
147 to fulfill equity goals is highly unlikely to achieve greater survival for these population groups, 
148 but will increase their risk of complications and may ultimately prolong their suffering.
149
150 The high proportions of people who die despite ICU admission make it particularly important 
151 to consider what might constitute better or worse experiences of dying with COVID-19, and 
152 how ICU admission affects the likelihood of a “good” death.  Critical care may compromise 
153 the ability of patients to communicate and engage with their families during the terminal 
154 phase of their lives – in the context of an intubated, ventilated patient this is unequivocal.  
155 Given the high rates of medical futility with COVID-19 patients in ICU, the very significant 
156 risks for further suffering in the short and long term and the compromise of important 
157 psychosocial needs – such as communicating with our families – in the terminal phase of life, 
158 our ethical scope must be wider than ICU triage. Ho and Tsai argue that “In considering 
159 effective and efficient allocation of healthcare resources as well as physical and 
160 psychological harm that can be incurred in prolonging the dying process, there is a critical 
161 need to reframe end-of-life care planning in the ICU.”(26) We propose that the focus on 
162 equity concerns during the pandemic should broaden to include providing all people who 
163 need it with access to the highest possible standard of end of life care. This requires 
Page 9 of 20
https://mc.manuscriptcentral.com/medethics





























































Confidential: For Review Only
9
164 attention to minimising barriers to accessing culturally safe care in the following interlinked 
165 areas: palliative care, and communication and decision support and advanced care planning. 
166
167 1. Palliative care
168
169 Scaling up palliative and hospice care is an essential component of the COVID-19 pandemic 
170 response. Avoiding non-beneficial or unwanted high-intensity care is critical when the 
171 capacity of the health system is stressed.(27) Palliative care focuses on symptom 
172 management, quality of life and death, and holistic care of physical, psychological, social 
173 and spiritual health.(28)  Evidence from Italy has prompted recommendations that 
174 “governments must urgently recognise the essential contribution of hospice and palliative 
175 care to the COVID-19 pandemic, and ensure these services are integrated into the health 
176 care system response.” (29) Rapid palliative care policy changes were implemented in 
177 response to COVID-19 in Italy, including more support in community settings, change in 
178 admission criteria, and daily telephone support for families.(29) To meet this increased 
179 demand, hospice and palliative care staff should be included in PPE allocation and provided 
180 with appropriate infection preventing and control (IPC) training hen dealing with COVID-19 
181 patients or high risk areas.   
182
183 Attention must also be directed to maintaining supply lines for essential medications for pain, 
184 distress and sedation. Patients may experience pain due to existing co-morbidities, but may 
185 also develop pain as a result of excessive coughing or immobility from COVID-19.  Such 
186 symptoms should be addressed using existing approaches to pain management.(28) Supply 
187 lines for essential medications for distress and pain management, including fentanyl and 
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188 midazolam are under threat in the United States and propofol – used in terminal sedation – 
189 may also be in short supply.(30) The challenges are exacerbated when people who for 
190 various reasons eschew or are unable to secure hospital admission decline rapidly at home 
191 with COVID-19 (the time frame of recognition that someone is dying and then of the dying 
192 process may be shorter than that through which hospice at home services usually support 
193 people).There is growing debate about the fair allocation of novel drugs – sometimes 
194 available as part of ongoing clinical trials –to treat COVID-19 with curative intent.(2,31) But 
195 we must also pay attention to the fair allocation of drugs needed to ease suffering and dying.  
196
197
198 2. Communication and end of life decision-making support
199
200 End of life planning can be especially challenging because patients, family members and 
201 health care providers often differ in what they consider most important near the end of 
202 life.(32)  Less than half of ICU physicians — 40.6 % in high income countries and 46.3 % in 
203 low-middle income countries — feel comfortable holding end-of-life discussions with patients’ 
204 families.(26) With ICUs bursting and health providers under extraordinary pressure, their 
205 capacity to effectively support end of life decisions and to ease dying will be reduced. 
206 This suggests a need for specialist COVID-19 communication support teams, analogous to 
207 the idea of specialist ICU triage teams to ensure consistency of decision making about ICU 
208 admissions/discharges, and to reduce the moral and psychological distress of health 
209 providers during the pandemic.(33) These support teams could provide up to date 
210 information templates for patients and families, support decision-making, the development of 
211 advance care plans (ACPs), and act as a  liaison between families (prevented from being in 
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212 the hospital), the patient and the clinical team. Some people with disabilities may require 
213 additional communication support to ensure the patients’ needs are communicated to all 
214 health providers, for example using whiteboards to display critical medical 
215 documentation.(34)  This will be especially important if carers and visitors are not able to be 
216 present.  
217 To provide effective and appropriate support in an equitable way, communication teams will 
218 need to include those with the appropriate skills for caring for diverse populations including: 
219 interpreters, specialist social workers, disability advocates, and cultural support liaison 
220 officers for ethnic and religious minorities. Patient groups that already have comparatively 
221 poor health outcomes require dedicated resources. These support resources are essential if 
222 we wish if we wish to truly mitigate equity concerns that arise in the acute setting. See Box 1:  
223 Supporting communication and compassionate care during pandemic for examples of 
224 specific communication and care strategies to support patients. 
225
226 3. Advance care planning 
227
228
229 Advance care plans (ACPs) aim to honour decisions made by autonomous patients if and 
230 when they lose capacity. However, talking to patients and their loved ones about clinical 
231 prognosis, ceilings of treatment and potential end of life care is challenging even in normal 
232 times.  During COVID-19 the challenges are exacerbated by uncertainty and urgency, the 
233 absence of family support (due to visitor restrictions), and the wearing of PPE by clinicians 
234 and carers. Protective equipment can create a formidable barrier between the patient and 
235 the provider, often adding to the patient’s sense of isolation and fear. An Australian palliative 
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236 care researcher with experience working in disaster zones, argues that the “PPE may 
237 disguise countenance, restrict normal human touch, and create an unfamiliar gulf between 
238 you and your patient.”(35)  The physical and psychological barriers of PPE coupled with the 
239 pressure of high clinical loads do not seem conducive to compassionate discussions about 
240 patients’ end of life preferences. Indeed, a study in Singapore during the 2004 SARS 
241 epidemic demonstrated the barrier posed by PPE to compassionate end of life care.(36) 
242
243 Clinicians may struggle to interpret existing ACPs in the context of COVID-19, given the 
244 unprecedented nature and scale of the pandemic and emerging clinical knowledge about the 
245 aetiology of the disease and (perhaps especially) about prognosis. This suggests the need 
246 for COVID-19-specific ACPs.  Where possible, proactive ACPs should occur with high-risk 
247 patients, the frail, those in residential care and those with significant underlying morbidities. 
248 Ideally, ACP conversations should take place prior to illness, involve known health providers 
249 and carers, not be hampered by PPE or subject to time constraints imposed by acute care 
250 contexts. Of note here, a systematic review found that patients who received advance care 
251 planning or palliative care interventions consistently showed a pattern toward decreased ICU 




256 How best to address equity concerns in relation to ICU and end of life care for COVID-19 
257 patients is challenging and complex.  Attempts to broaden clinical criteria to give patients 
258 with poorer prognoses access to ICU on equity grounds may result in fewer lives saved 
259 overall – this may well be justified if access to ICU confers benefit to these “equity” patients. 
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260 But we must avoid tokenistic gestures to equity – admitting patients with poor prognostic 
261 indicators to ICU to meet an equity target when intensive critical care is contrary to their best 
262 interests.  ICU admission may exacerbate and prolong suffering rather than ameliorate it, 
263 especially for frailer patients; and prolonging life at all costs may ultimately lead to a worse 
264 death. The capacity for harm not just the capacity for benefit should be emphasized in any 
265 triage tools and related literature. Equity can be addressed more robustly if pandemic 
266 responses scale up investment in palliative care services, communication and decision-
267 support services and advanced care planning to meet the needs of all COVID-19 patients.  
268 Ultimately, however, equity considerations will require us to move even further from a critical 
269 care framework as the social and economic impact of the pandemic will disproportionately 
270 impact those most vulnerable.  Globally, we will need an approach that doesn’t just stop an 
271 exponential rise in infections but an exponential rise in inequality.
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Box 1: Supporting communication and compassionate care during pandemics
Despite the sometimes overwhelming pressure of the pandemic, health providers continue to 
invest in communication, compassionate care, and end of life support. In some places, 
doctors have taken photos of their faces and taped these to the front of their PPE so that 
patients can “see” their face.(38) In Singapore, patients who test positive for coronavirus are 
quarantined in health facilities until they receive two consecutive negative tests. Patients 
may be isolated in hospital for several weeks. To help ease this burden on patients, health 
providers have dubbed themselves the “second family” and gone out of their way to provide 
care as well as treatment. [see comic below, we have permission to use this, to be 
discussed with JME editors] Elsewhere, medical, nursing and multi-disciplinary teams are 
utilising internet based devices to enable ‘virtual’ visits and contact between patients and 
their loved ones.(39) Some centres are providing staff with masks with a see-through 
window panel that shows the wearer’s mouth, to support effective communication with 
patient with hearing loss who rely on lip reading.(40)
Page 15 of 20
https://mc.manuscriptcentral.com/medethics





























































Confidential: For Review Only
15
Page 16 of 20
https://mc.manuscriptcentral.com/medethics





























































Confidential: For Review Only
16
REFERENCES
1. World Health Organization. Equity.  https://www.who.int/healthsystems/topics/equity/en/
2. Emanuel EJ, Persad G, Upshur R. et al Fair Allocation of Scarce Medical Resources in the Time 
of Covid-19. N Engl J Med. 2020 Mar 23. doi: 10.1056/NEJMsb2005114. [Epub ahead of 
print]
3. Ballantyne A. ICU triage: How many lives or whose lives? Journal of Medical Ethics Blog. 7 
April 2020  https://blogs.bmj.com/medical-ethics/2020/04/07/icu-triage-how-many-lives-or-
whose-lives/
4. Schmidt H. The Way We Ration Ventilators Is Biased. The New York Times. 15 April 2020 
https://www.nytimes.com/2020/04/15/opinion/covid-ventilator-rationing-blacks.html 
5. Stramondo J. COVID-19 Triage and Disability: What NOT To Do. Bioethics.net blog. 30 March 
2020 http://www.bioethics.net/2020/03/covid-19-triage-and-disability-what-not-to-do 
6. Leach Scully, J. Disablism In a Time of Pandemic: Some Things Don’t Change. IJFAB blog. 1 
April 2020. ijfab.org/blog/author/jackieleachscully/  
7. The Hasting Centre. Structural Racism, White Fragility, and Ventilator Rationing Policies. 
Bioethics.net blog. 20 April 2020 http://www.bioethics.net/2020/04/structural-racism-
white-fragility-and-ventilator-rationing-policies/ 
8. Gierl H, Plantsch M,  Schweidler J. Scarcity effects on sales volume in retail. International 
Review of Re-tail, Distribution and Consumer Research, 2008: 18, 45–61 
9. Brock TC. Implications of commodity theory for value change. In Anthony G. Greenwald, 
Timothy C. Brock, &Thomas M. Ostrom (Eds.), Psychological foundations of attitudes 1968. 
(pp. 243–275). New York: Academic Press.
10. Zagury-Orly I, Schwartzstein RM.Covid-19 - A Reminder to Reason. N Engl J Med. 2020 Apr 
28. doi: 10.1056/NEJMp2009405. [Epub ahead of print]
11. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus 
Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the 
Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. 
doi:10.1001/jama.2020.2648
12. Johnson CY, Cha AE.  The dark side of ventilators: Those hooked up for long periods face 
difficult recoveries. The Washington Post.  7 April 2020 
https://www.washingtonpost.com/health/2020/04/03/coronavirus-survivors-recovery/ 
13. Yang X, Yu Y, Xu J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 
pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet 
Respir Med. 2020; 8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. 
Page 17 of 20
https://mc.manuscriptcentral.com/medethics





























































Confidential: For Review Only
17
14. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and 
Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. 
JAMA. April 22, 2020. doi:10.1001/jama.2020.6775 
15. Wise J. A third of covid-19 patients admitted to UK hospitals die. BMJ2020;369: m1794. 
doi:10.1136/bmj.m1794 pmid:32354787 
16. Kalanuria, A. A., Ziai, W., & Mirski, M. (2014). Ventilator-associated pneumonia in the ICU. 
Critical care (London, England), 18(2), 208. https://doi.org/10.1186/cc13775
17. Shepherd S, Batra A, Lerner DP. Review of Critical Illness Myopathy and Neuropathy. 
Neurohospitalist. 2017;7(1):41-48. doi:10.1177/1941874416663279
18. Johnson CY, Cha AE.  The dark side of ventilators: Those hooked up for long periods face 
difficult recoveries. The Washington Post. 7 April 2020 
https://www.washingtonpost.com/health/2020/04/03/coronavirus-survivors-recovery/
19. Hashem MD, Nallagangula A, Nalamalapu S. et al. Patient outcomes after critical illness: a 
systematic review of qualitative studies following hospital discharge. Crit Care. 2016 Oct 
26;20(1):345.
20. Parker A, Sricharoenchai T, Needham DM. Early rehabilitation in the intensive care unit: 
preventing physical and mental health impairments. Curr Phys Med Rehabil Rep 2013;1: 
307-14.   doi:10.1007/s40141-013-0027-9 pmid:24436844
21. Parker AM, Sricharoenchai T, Raparla S, Schneck KW, Bienvenu OJ, Needham 
DM.Posttraumatic stress disorder in critical illness survivors: a metaanalysis. Crit Care Med. 
2015 ;43(5):1121-9. doi: 10.1097/CCM.0000000000000882.
22. Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical 
illness. N Engl J Med. 2013;369(14):1306–1316. doi:10.1056/NEJMoa1301372
23. Kamdar BB, Huang M, Dinglas VD et al. Joblessness and Lost Earnings after Acute Respiratory 
Distress Syndrome in a 1-Year National Multicenter Study. Am J Respir Crit Care Med. 2017; 
15;196(8):1012-1020. doi: 10.1164/rccm.201611-2327OC.
24. Thornton J. Covid-19: the challenge of patient rehabilitation after intensive care BMJ 2020; 
369 :m1787
25. Cameron JI, Chu LM, Matte A. One-Year Outcomes in Caregivers of Critically Ill Patients. N 
Engl J Med. 2016 May 12;374(19):1831-41. doi: 10.1056/NEJMoa1511160.
26. Ho A, Tsai DF. Making good death more accessible: end-of-life care in the intensive care unit. 
Intensive Care Med 2016; 42, 1258–1260. https://doi.org/10.1007/s00134-016-4396-2
Page 18 of 20
https://mc.manuscriptcentral.com/medethics





























































Confidential: For Review Only
18
27. Curtis JR, Kross EK, Stapleton RD. The Importance of Addressing Advance Care Planning and 
Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus 2019 (COVID-19). 
JAMA. Published online March 27, 2020. doi:10.1001/jama.2020.4894
28. Lawrie I, Murphy F. COVID-19 and Palliative, End of Life and Bereavement Care in Secondary 
Care. 22 March 2020.  https://apmonline.org/wp-content/uploads/2020/03/COVID-19-and-
Palliative-End-of-Life-and-Bereavement-Care-22-March-2020.pdf
29. Costantini, Massimo & Sleeman, Katherine & Peruselli, Carlo & Higginson, Irene. (2020). 
Response and role of palliative care during the COVID-19 pandemic: a national telephone 
survey of hospices in Italy. 10.1101/2020.03.18.20038448.
30. Sheikh, K. Essential Drug Supplies for Virus Patients Are Running Low. The New York Times. 2 
April 2020.  https://www.nytimes.com/2020/04/02/health/coronavirus-drug-shortages.html
31. Kolata G. Haphazard Rollout of Coronavirus Drug Frustrates Doctors. New York Times  8 May 
2020. nytimes.com/2020/05/08/health/coronavirus-remdesivir-hospitals.html
32. Meier, Emily A. et al. Defining a Good Death (Successful Dying): Literature Review and a Call 
for Research and Public Dialogue. The American Journal of Geriatric Psychiatry, Volume 24, 
Issue 4, 261 - 271
33. Truog, R. Mitchell, C. Daley, GQ.  The Toughest Triage — Allocating Ventilators in a 
Pandemic.  NEJM, March 2020, 
https://www.nejm.org/doi/pdf/10.1056/NEJMp2005689?articleTools=true
34. Guirdy-Grimes, L et al 2020. Disability Rights as a Necessary Framework for Crisis Standards 
of Care and Future Health Care Delivery. Hastings Centre Report Special Issue (Under Review 
– will update reference prior to publication.)






36. Leong IY, Lee AO, Ng TW, The challenge of providing holistic care in a viral epidemic: 
opportunities for palliative care. Palliat Med. 2004 Jan;18(1):12-8. 
37. Khandelwal N, Kross EK, Engelberg RA, et al. Estimating the effect of palliative care 
interventions and advance care planning on ICU utilization: a systematic review. Crit Care 
Med. 2015 May;43(5):1102-11. doi: 10.1097/CCM.0000000000000852.
38. https://twitter.com/HananyaNaftali/status/1246799853675520000/photo/1 
Page 19 of 20
https://mc.manuscriptcentral.com/medethics





























































Confidential: For Review Only
19
39. Martieau P. iPads Are Crucial Health Care Tools in Combating Covid-19. 8 April 2020. Wired. 
https://www.wired.com/story/ipads-crucial-health-tools-combating-covid-19/
40. Trecca EMC, Gelardi M, Cassano M. COVID-19 and hearing difficulties [published online 
ahead of print, 2020 Apr 19]. Am J Otolaryngol. 2020;102496. 
doi:10.1016/j.amjoto.2020.102496
Page 20 of 20
https://mc.manuscriptcentral.com/medethics





























































Confidential: For Review Only
 
Compassionate care during COVID-19. With thanks to the NUS Medicine Covid-19 Chronicles strips. 
117x176mm (150 x 150 DPI) 
Page 21 of 20
https://mc.manuscriptcentral.com/medethics
Journal of Medical Ethics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
